TRAPPC14
Trafficking protein particle complex subunit 14
Also known as: C7orf43, FLJ10925, MAP11, TPC14_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WVR3
- Gene
- TRAPPC14
- Ensembl
- ENSG00000146826
- Chromosome
- 7
- Canonical length
- 580 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane,Centriolar satellite
OverviewNCBI Gene
Enables alpha-tubulin binding activity. Involved in cilium assembly and regulation of cell population proliferation. Located in several cellular components, including microtubule cytoskeleton; midbody; and plasma membrane. Part of TRAPPII protein complex. Implicated in primary autosomal recessive microcephaly 25. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
580 residues, UniProt reviewed canonical sequence.
>Q8WVR3|TRAPPC14
1 MESQCDYSMY FPAVPLPPRA ELAGDPGRYR ALPRRNHLYL GETVRFLLVL RCRGGAGSGT
61 GGGPGLGSRG AWAELATALA ALASVSAGGG MPGGGGAGDQ DSEPPGGGDP GGGGLFRGCS
121 PLLTHGPGPA TSGGATTLPV EEPIVSTDEV IFPLTVSLDR LPPGTPKAKI VVTVWKREIE
181 APEVRDQGYL RLLQTRSPGE TFRGEQSAFK AQVSTLLTLL PPPVLRCRQF TVAGKHLTVL
241 KVLNSSSQEE ISIWDIRILP NFNASYLPVM PDGSVLLVDN VCHQSGEVSM GSFCRLPGTS
301 GCFPCPLNAL EEHNFLFQLR GGEQPPPGAK EGLEVPLIAV VQWSTPKLPF TQSIYTHYRL
361 PSVRLDRPCF VMTASCKSPV RTYERFTVTY TLLNNLQDFL AVRLVWTPEH AQAGKQLCEE
421 ERRAMQAALD SVVCHTPLNN LGFSRKGSAL TFSVAFQALR TGLFELSQHM KLKLQFTASV
481 SHPPPEARPL SRKSSPSSPA VRDLVERHQA SLGRSQSFSH QQPSRSHLMR SGSVMERRAI
541 TPPVASPVGR PLYLPPDKAV LSLDKIAKRE CKVLVVEPVKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAPPC14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- spleen: 31 nTPM
- cerebellum: 29 nTPM
- testis: 29 nTPM
- skin: 24 nTPM
- small intestine: 21 nTPM
- lymph node: 19 nTPM
Single-cell type
- syncytiotrophoblasts: 20 nCPM
- colonocytes: 19 nCPM
- neutrophils: 19 nCPM
- esophageal apical cells: 14 nCPM
- microglia: 14 nCPM
- late primary spermatocytes: 13 nCPM
Immune cell
- neutrophil: 1.9 nTPM
- eosinophil: 1.4 nTPM
- memory CD4 T-cell: 0.8 nTPM
- naive CD8 T-cell: 0.7 nTPM
- basophil: 0.6 nTPM
- gdT-cell: 0.6 nTPM
Brain region
- pons: 27 nTPM
- hypothalamus: 27 nTPM
- thalamus: 26 nTPM
- medulla oblongata: 26 nTPM
- midbrain: 26 nTPM
- cerebral cortex: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRAPPC14.
Disease | AllUniProt
Conditions TRAPPC14 is implicated in, by any mechanism.
- Microcephaly 25, primary, autosomal recessive (MCPH25) MIM:618351
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 26 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Microcephaly 25, primary, autosomal recessive
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.18
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Trafficking protein particle complex subunit 14
- TRAPP14, C-terminal
- TRAPP14, N-terminal
- TRAPP14 N-terminal
- TRAPP14 C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAPPC14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAPPC14 as an antibody target. Whether an autoantibody or antibody against TRAPPC14 could matter depends on whether native TRAPPC14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAPPC14 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRAPPC14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...